TriangleNeural Stem Cells-expressing… (NCT05139056)
Neural Stem Cells-expressing CRAd-S-pk7 trial for Currently Only Enrolling Glioblastoma Patients at First Recurrence (NCT05139056). This is a short film with English narration. The transcript is on this page, and the written brief is separate.
What the film says
Read the transcript
When glioblastoma comes back, most patients have under a year. Viruses engineered to kill cancer cells show promise, but spread poorly through brain tissue.
The idea: load the virus into cells that naturally migrate toward tumors, and let them carry it.
Neural stem cells home to gliomas. At City of Hope, banked cells are loaded with an adenovirus built to replicate only in cancer cells. During surgery to remove the recurrent tumor, the first dose goes into the cavity walls, where invading cells remain. Three more doses follow through a catheter left in place, weekly or every two weeks.
Enrolling glioblastoma at first recurrence at City of Hope, Stanford, Northwestern, and Wake Forest. Jana Portnow leads it. Public record; not medical advice.
Already in a trial?
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.
How these trials work: what Phase 1 actually is · common questions Not clinical evidence.